Joel R. Jung's most recent trade in Renalytix Plc - ADR was a trade of 60,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Renalytix Plc - ADR | Joel R. Jung | Interim Chief Financial Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
Minerva Surgical Inc | Joel R. Jung | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 60,198 | 220,730 | - | 0 | Common Stock |